Flurbiprofen, 98%
Flurbiprofen, 98%
Flurbiprofen, 98%
Thermo Scientific Chemicals

Flurbiprofen, 98%

Flurbiprofen, CAS # 5104-49-4, is a monocarboxylic acid-based nonsteroidal anti-inflammatory (NSAID).
Have Questions?
變更視圖buttonViewtableView
產品號碼Quantity
4546600101g
4546600505g
45466025025g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
產品號碼 454660010
價格 (TWD)
-
Quantity:
1g
Request bulk or custom format
化學識別
CAS5104-49-4
IUPAC Name2-{2-fluoro-[1,1'-biphenyl]-4-yl}propanoic acid
Molecular FormulaC15H13FO2
InChI KeySYTBZMRGLBWNTM-UHFFFAOYNA-N
SMILESCC(C(O)=O)C1=CC=C(C(F)=C1)C1=CC=CC=C1
檢視更多
規格Specification Sheet規格表
Infrared spectrumConforms
Appearance (Form)Powder
Melting point110°C to 116°C
HPLC>=97.5 %
Appearance (Color)White to off-white
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

• Flurbiprofen is composed of a 2-fluoro-[1,1'-biphenyl-4-yl] moiety attached to propionic acid

• Flurbiprofen works by inhibiting prostaglandin-endoperoxide synthase and reducing the production of prostaglandins and pyrogens

Applications

• Flurbiprofen is useful for studying pathways associated with prostaglandin production

• It is suitable for laboratory research on pain, inflammation, ocular pressure, and postoperative recovery

RUO – Research Use Only

Literature References

Sun, M.; Cong, X.; Chang, E.; Miao, M.; Zhang, J. Efficacy of Flurbiprofen for Postoperative Pain in Chinese Surgical Patients: A Meta-Analysis. J Surg Res. 2020, 252:80-88.

Caban-Toktas, S.; Sahin, A.; Lule, S.; Esendagli, G.; Vural, I.; Karlı Oguz, K.; Soylemezoglu, F.; Mut, M.; Dalkara, T.; Khan, M.; Capan, Y. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Int J Pharm. 2020, 578,119076.